Document is current
Any future updates will be listed below
-
Authors
Bihari, Shailesh
Costell, Melissa H.
Bouchier, Tara
Behm, David J.
Burgert, Mark
Ye, Guosen
Bersten, Andrew D.
Puukila, Stephanie
Cavallaro, Elena
Sprecher, Dennis L.
Dixon, Dani-Louise https://orcid.org/0000-0001-6459-1856
-
Funding
Funding for this research was provided by:
GlaxoSmithKline, United States
Flinders University
- License Information
-
More Information
Article History
Received: 4 April 2023
Accepted: 26 October 2023
First Online: 15 November 2023
Declarations
:
: Financial interests: GSK partially funded the study. SB, TB, ADB, SP, EC and DLD have no other conflicts to declare. MHC, DJB and DLS were GlaxoSmithKline (GSK) employees when the work was performed. GSK provided support in the form of salaries for these authors (MHC, DJB, GY, MB, and DLS).
: Study 1 was performed in accordance with the Guide for the Care and Use of Laboratory Animals: Eighth Edition (National Research Council, 2011), the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the U.S. National Institutes of Health, and the GlaxoSmithKline (GSK) Policy on the Care, Welfare and Treatment of Laboratory Animals, and were approved by the Institutional Animal Care and Use Committee at GSK.Study 2 and 3 were approved by the Flinders University Animal Welfare Committee, Adelaide, Australia, and conducted according to guidelines from the National Health and Medical Research Council, Australia.
